Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
01/2012
01/04/2012CN101628113B Application of earthworm fibrinolytic enzyme in resistance to liver fibrosis
01/04/2012CN101564533B Hepatitis E protein-nucleic acid composite vaccine and preparation method thereof
01/04/2012CN101564528B Chinese traditional medicine for curing diarrhea and preparation method thereof
01/04/2012CN101472565B Preparation method of granular formulation
01/04/2012CN101444551B Rhizoma atractylodis arborinol inclusion compound, medicinal combination thereof and preparation method
01/04/2012CN101352493B Chinese medicine with functions for reducing fat and clearing liver and preparation method thereof
01/04/2012CN101293083B Pharmaceutical composition and preparation method thereof
01/04/2012CN101292741B Health care bamboo salt with mind pacifying and digestion promoting function, and method of preparing the same
01/04/2012CN101214000B Health preserving health tea for female intestinal canal
01/04/2012CN101152294B Traditional Chinese medicine soft capsule and its preparing method
01/03/2012US8088906 FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof
01/03/2012US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
01/03/2012US8088802 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
01/03/2012US8088762 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
01/03/2012US8088571 Methods of reducing a viral infection and kits therefore
01/03/2012US8088383 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
01/03/2012CA2514407C Thienopyrimidine compounds and use thereof
01/03/2012CA2496902C Medicament for activating the phagocytic capacity of macrophages
01/03/2012CA2489128C 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
01/03/2012CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
01/03/2012CA2481321C [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
01/03/2012CA2463974C Dendrimers for use in targeted delivery
01/03/2012CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
01/03/2012CA2446254C New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits
01/03/2012CA2445835C 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
01/03/2012CA2436049C A serpin in bifidobacteria
01/03/2012CA2395684C Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/2011
12/30/2011CA2744562A1 Non-alcohol bioactive essential oil mouth rinses
12/29/2011WO2011163539A2 nAChRα7 AGONISTS AND nAChRα7 ANTAGONISTS FOR TREATING ULCERATIVE COLITIS (UC) AND CROHN'S DISEASE (CD)
12/29/2011WO2011163469A1 Hydrated form of anti-inflammatory roflumilast-n-oxide
12/29/2011WO2011162835A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
12/29/2011WO2011162409A1 Compounds having trpv1 antagonistic activity and uses thereof
12/29/2011WO2011161421A1 Salts and polymorphs of dexrabeprazole
12/29/2011WO2011160434A1 Preparing process and quality controlling method for an compound injection
12/29/2011WO2011160259A1 Use of n-carbamoyl glutamic acid, salts or esters thereof in manufacture of health care products for protecting liver or promoting muscle growth
12/29/2011WO2011119738A9 Methods of treatment using stem cell mobilizers
12/29/2011WO2011091366A3 Methods of treating or preventing periodontitis and diseases associated with periodontitis
12/29/2011US20110319497 Ampk activator
12/29/2011US20110319490 Methods and compositions for the treatment of irritable bowel syndrome
12/29/2011US20110319485 Composition Having Anti-Helicobacter Pylori Activity And Its Application To Inhibit Helicobacter Pylori
12/29/2011US20110319479 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia
12/29/2011US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
12/29/2011US20110319468 Cyclic amine compounds
12/29/2011US20110319461 Novel salts, polymorphs, and synthetic processes regarding imidazole derivative
12/29/2011US20110319450 Benzimidazole compound crystal
12/29/2011US20110319449 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
12/29/2011US20110319446 Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
12/29/2011US20110319440 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds
12/29/2011US20110319439 Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
12/29/2011US20110319438 Novel sulfonamides as l-cpt1 inhibitors
12/29/2011US20110319433 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation
12/29/2011US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
12/29/2011US20110319420 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor
12/29/2011US20110319410 Pyrazine derivatives and use as pi3k inhibitors
12/29/2011US20110319408 Methods of Treating Fibrosis, Cancer and Vascular Injuries
12/29/2011US20110319397 Novel n-oxides of furanyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
12/29/2011US20110319390 6-Aminoisoquinoline Compounds
12/29/2011US20110319381 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
12/29/2011US20110319368 Once daily formulations of tetracyclines
12/29/2011US20110319343 Agonists Of Guanylate Cyclase Useful For The Treatment Of Gastrointestinal Disorders, Inflammation, Cancer And Other Disorders
12/29/2011US20110319330 Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury
12/29/2011US20110319328 Bone morphogenetic protein compositions
12/29/2011US20110319326 Derivatives of benzothiazines, preparation thereof and application thereof as drugs
12/29/2011US20110319323 Pharmaceutical composition and method of use to improve organ function
12/29/2011US20110319321 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
12/29/2011US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1
12/29/2011US20110319267 Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
12/29/2011US20110318432 Compositions for the treatment of gastro-esofageal reflux disease (gerd)
12/29/2011US20110318431 Pharmaceutical Compositions and Methods of Treating Neurological Insults
12/29/2011US20110318388 S1P Receptors Modulators and Their Use Thereof
12/29/2011US20110318379 Vaccine for Porcine Post-Weaning Diarrhea Caused by Enterotoxigenic Escherichia Coli
12/29/2011US20110318367 Novel targets for treatment of hypercholesterolemia
12/29/2011US20110318340 Deglycosylated antibodies
12/29/2011US20110318318 Anti-apoptotic fusion proteins
12/29/2011US20110318310 Method for enhancing stem cell trafficking
12/29/2011US20110318281 Lactobacillus Salivarius SG-M6 for Improving Oral Bacterial Groups and Health Care Compositions Thereof
12/29/2011CA2803673A1 Salts and polymorphs of dexrabeprazole
12/29/2011CA2788398A1 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
12/28/2011EP2399930A1 N-terminally monopegylated polypeptides and process for their preparation
12/28/2011EP2399914A1 Fused heterocyclic ring compound
12/28/2011EP2399903A1 Ccr9 inhibitors and methods of use thereof
12/28/2011EP2399600A1 Treatment of inflammatory bowel diseases with mammal beta defensins
12/28/2011EP2399588A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/28/2011EP2399576A1 Use of antibacterial compounds for the oral cavity hygiene
12/28/2011EP2398470A1 Controlled-release compositions comprising a proton pump inhibitor
12/28/2011EP2398325A1 Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids
12/28/2011EP1971341B1 Use of morpholino compounds for the treatment of halitosis
12/28/2011EP1664036B1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity
12/28/2011CN1824131B 一种胃铋镁药物组合物 One kind of pharmaceutical composition stomach bismuth magnesium
12/28/2011CN102300847A Ppar激动剂组合物及其使用方法 Ppar agonist compositions and methods of use
12/28/2011CN102300570A 用于治疗肝炎的水飞蓟宾组分 For the treatment of hepatitis silibinin component
12/28/2011CN102296011A 一种松花养身酒的制备方法 A method for preparing the Songhua wine cultivation
12/28/2011CN102295637A 5-lipoxygenase-activating protein (FLAP) inhibitors
12/28/2011CN102295593A 一种具有保护酒精性肝损伤功能的新型硒酸生物材料 A kind of alcoholic liver injury protection features of the new biomaterials selenate
12/28/2011CN102294034A 一种生物矿化材料及其制备方法与应用 A biological mineralized material and its preparation method and application
12/28/2011CN102294031A 含质子泵抑制剂、nsaid和抗酸剂的药物制剂 Pharmaceutical formulation containing a proton pump inhibitor, nsaid and antacid
12/28/2011CN102294020A 空间构象改变的干扰素及其应用 Spatial conformational changes interferon and its Application
12/28/2011CN102294014A 一种促肝细胞生长素,其制剂和用途 A pro-hepatocyte growth factor, their preparation and use
12/28/2011CN102294013A 一种促肝细胞生长素,其制剂及应用 A pro-hepatocyte growth factor, and its preparation and application
12/28/2011CN102294012A 一种治疗泄泻的中药组合物 A treatment for diarrhea medicine composition